Tutkijat / Oulu  | Ala-Kokko, L. |
| Ala-Kokko, T(ero) |
| Ala-Korpela, M(ika) |
| Alahuhta, S. |
| Alén, M(arkku) |
| Antikainen, R. |
| Anttonen, V(uokko) |
| Biancari, F(austo) |
| Bloigu, R(isto) |
| Eskelinen, S. |
| Flinkkilä, T(apio) |
| Hakkola, J. |
| Hallman, M. |
| Hartikainen, A(nna)-L(iisa) |
| Hausen, H. |
| Hautala, N(ina) |
| Hautala, T(imo) |
| Heape, A. |
| Herzig, K(arl)-H(einz) |
| Hillbom, M. |
| Hiltunen, J.K. |
| Hörkko, S. |
| Huikuri, H(eikki) |
| Hukkanen J(anne) |
| Ignatius, J. |
| Isohanni, M. |
| Jaakkola, J. |
| Jaakkola, M(aritta) S. |
| Jaakola, V-P. |
| Jämsä, T(imo) |
| Janhonen, S. |
| Jartti, T(uomas) |
| Järvelin, M(arjo)-R(iitta) |
| Jokelainen, J(ari) |
| Juffer, A(ndré) H. |
| Junttila, J(uhani) |
| Juvonen, T. |
| Kaarteenaho, R(iitta) |
| Kajantie, E(ero)*(THL/OY) |
| Karppinen (Koivunen), P(eppi) |
| Karppinen, J(aro) |
| Karttunen, T.J. |
| Keinänen-Kiukaanniemi, S(irkka) |
| Kerkelä, R(isto) |
| Kesäniemi, Y(rjö) A(ntero) |
| Kettunen, J(ohannes) |
| Kietzmann, T(homas). |
| Kivirikko, K.I. |
| Knuuttila, M. |
| Koivukangas, J. |
| Kursula, P(etri) |
| Kyngäs, H. |
| Larivaara, P. |
| Larmas, M. |
| Lehenkari, P(etri) |
| Lehtiö, L(ari) |
| Leppilahti, J. |
| Luukinen, H. |
| Mainio A |
| Majamaa, K. |
| Mäki, P(irjo) |
| Mäkikallio, T(imo) H. |
| Männikkö, M(inna) |
| Manninen, A(ki). |
| Martikainen, H(annu) |
| Miettunen, J(ouko) |
| Myllyharju, J(ohanna) |
| Myllylä, R. |
| Myllylä, V. |
| Näyhä, S(imo) |
| Neubauer, P. |
| Nieminen, M(iika) T. |
| Nieminen, P(entti) |
| Niinimäki, J(aakko) |
| Ohukainen, P(auli) |
| Oikarinen, A. |
| Oikarinen, K. |
| Pelkonen, O(lavi) |
| Petäjä-Repo, U.E. |
| Pihlajaniemi, T(aina) |
| Pirttiniemi, P(ertti) |
| Puistola, U(lla) |
| Rajaniemi, H.J. |
| Räsänen, P. |
| Raustia, A. |
| Remes, A(nne) |
| Risteli, J. |
| Ristiniemi, J. |
| Ruddock, L.W. |
| Ruokonen, A. |
| Ryynänen, M. |
| Saarakkala, S. |
| Saari, A. |
| Salo, T(uula) |
| Sándor, G(eorge) K. |
| Savolainen, E-R. |
| Savolainen, M.J. |
| Savolainen, O. |
| Sillanpää, M(ikko). |
| Soininen, R. |
| Sorri, M. |
| Taanila, A. |
| Tapiainen, T(erhi) |
| Tervonen, O(smo) |
| Timonen, M(arkku) |
| Turpeenniemi-Hujanen, T. |
| Tuukkanen, J(uha) |
| Tuulonen, A. |
| Uhari, M. |
| Ukkola, O(lavi) |
| Uusimaa, J. |
| Vainio, O. |
| Vainio, S. |
| Väyrynen, J(uha) P. |
| Veijola, J(uha) |
| Veijola, R(iitta) |
| Virokannas, H. |
| Voipio, H(anna)-M(arja) |
| Vuolteenaho, O. |
| Weckström, M. |
| Wei, GH. |
| Wierenga, R.K. |
| Winqvist, R(obert) |
| Ylänne, J. |
| Ylitalo, K(ari) |
Scholar Chart >>
|
»My Articles
»Latest Feeds
»Popular Feeds |
| | G Protein-Coupled Receptors in the Sweet Spot: Glycosylation and other Post-translational Modifications | Petäjä-Repo, U.E. | 2 days | save |  |  |  |  |
| Novel congenital disorder of O-linked glycosylation caused by GALNT2 loss of function | Petäjä-Repo, U.E. | 2 days | save | | | | |
| The N-terminal domain of unknown function (DUF959) in collagen XVIII is intrinsically disordered and highly O-glycosylated | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Site-specific O-glycosylation of N-terminal serine residues by polypeptide GalNAc-transferase 2 modulates humanδ-opioid receptor turnover at the plasma membrane | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Site-specific <em>O</em>-Glycosylation by Polypeptide <em>N</em>-Acetylgalactosaminyltransferase 2 (GalNAc-transferase T2) Co-regulatesβ<sub>1</sub>-Adrenergic Receptor N-terminal Cleavage | Petäjä-Repo, U.E. | 2 days | save | | | | |
| The Parkinson's-disease-associated receptor GPR37 undergoes metalloproteinase-mediated N-terminal cleavage and ectodomain shedding | Petäjä-Repo, U.E. | 2 days | save | | | | |
| N-Glycan-dependent and -independent quality control of humanδ opioid receptor N-terminal variants | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Targeting opioid receptors with pharmacological chaperones | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Allele-specific N-glycosylation delays human surfactant protein B secretion in vitro and associates with decreased protein levels in vivo | Petäjä-Repo, U.E. | 2 days | save | | | | |
| β-Adrenergic agonists mediate enhancement of β1-adrenergic receptor N-terminal cleavage and stabilization in vivo and in vitro | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Cys-27 variant of humanδ-opioid receptor modulates maturation and cell surface delivery of Phe-27 variant via heteromerization | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Cysteine 27 variant of the delta-opioid receptor affects amyloid precursor protein processing through altered endocytic trafficking | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Phe27Cys polymorphism of the human delta opioid receptor predisposes cells to compromised calcium signaling | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Association of the beta-1 adrenergic receptor carboxyl terminal variants with left ventricular hypertrophy among diabetic and non-diabetic survivors of acute myocardial infarction | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Human beta1-adrenergic receptor is subject to constitutive and regulated N-terminal cleavage | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Human delta opioid receptor biogenesis is regulated via interactions with SERCA2b and calnexin | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Phe27Cys polymorphism alters the maturation and subcellular localization of the human delta opioid receptor | Petäjä-Repo, U.E. | 2 days | save | | | | |
| N-glycan-mediated quality control in the endoplasmic reticulum is required for the expression of correctly folded delta-opioid receptors at the cell surface | Petäjä-Repo, U.E. | 2 days | save | | | | |
| The endoplasmic reticulum Ca2+-pump SERCA2b interacts with G protein-coupled receptors and enhances their expression at the cell surface | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Opioid receptor pharmacological chaperones act by binding and stabilizing newly synthesized receptors in the endoplasmic reticulum | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Distinct subcellular localization for constitutive and agonist-modulated palmitoylation of the human delta opioid receptor | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Luteinizing hormone receptor ectodomain splice variant misroutes the full-length receptor into a subcompartment of the endoplasmic reticulum | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Inefficient maturation of the rat luteinizing hormone receptor. A putative way to regulate receptor numbers at the cell surface | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Expression of the mature luteinizing hormone receptor in rodent urogenital and adrenal tissues is developmentally regulated at a posttranslational level | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Identification and structural characterization of the neuronal luteinizing hormone receptor associated with sensory systems | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Association of calnexin with wild type and mutant AVPR2 that causes nephrogenic diabetes insipidus | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Pharmacological chaperones: a new twist on receptor folding | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Newly synthesized human delta opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, deglycosylated, ubiquitinated, and degraded by the proteasome | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human delta opioid receptor | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Structure and functional significance of the carbohydrates of the LH/CG receptor | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Structural characterization of the carbohydrates of the rat ovarian luteinizing hormone/chorionic gonadotropin receptor | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Significance of the extracellular domain and the carbohydrates of the human neutrophil N-formyl peptide chemotactic receptor for the signal transduction by the receptor | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Significance of the carbohydrate moiety of the rat ovarian luteinizing-hormone/chorionic-gonadotropin receptor for ligand-binding specificity and signal transduction | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Rat and human neutrophil N-formyl-peptide chemotactic receptors. Species difference in the glycosylation of similar 35-38 kDa polypeptide cores | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Significance of the glycan moiety of the rat ovarian luteinizing hormone/chorionic gonadotropin (CG) receptor and human CG for receptor-hormone interaction | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Receptors of glycoprotein hormones | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Subunit interaction of human chorionic gonadotropin (hCG) with rat ovarian luteinizing hormone (LH)/CG receptor | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Structural features of the LH/CG receptor | Petäjä-Repo, U.E. | 2 days | save | | | | |
| Molecular structure of the luteinizing hormone receptor | Petäjä-Repo, U.E. | 2 days | save | | | | |
| G Protein-Coupled Receptors in the Sweet Spot: Glycosylation and other Post-translational Modifications. | Petäjä-Repo, U.E. | 315 days | save | | | | |
| Novel congenital disorder of O-linked glycosylation caused by GALNT2 loss of function. | Petäjä-Repo, U.E. | 316 days | save | | | | |
| The N-terminal Domain of Unknown Function (DUF959) in Collagen XVIII is Intrinsically Disordered and Highly O-glycosylated. | Petäjä-Repo, U.E. | 862 days | save | | | | |
| Site-specific O-glycosylation of N-terminal serine residues by polypeptide GalNAc-transferase 2 modulates humanδ-opioid receptor turnover at the plasma membrane. | Petäjä-Repo, U.E. | 1210 days | save | | | | |
| Site-specific O-glycosylation by Polypeptide GalNAc-transferase T2 Co-regulates Beta1-adrenergic Receptor N-terminal Cleavage. | Petäjä-Repo, U.E. | 1478 days | save | | | | |
| Parkinson's disease-associated GPR37 undergoes metalloproteinase-mediated N-terminal cleavage and ectodomain shedding. | Petäjä-Repo, U.E. | 1840 days | save | | | | |
| N-Glycan Dependent and Independent Quality Control of Human Delta Opioid Receptor N-Terminal Variants. | Petäjä-Repo, U.E. | 2487 days | save | | | | |
| Targeting opioid receptors with pharmacological chaperones. | Petäjä-Repo, U.E. | 2624 days | save | | | | |
| Allele-specific N-glycosylation delays human surfactant protein B secretion in vitro and associates with decreased protein levels in vivo. | Petäjä-Repo, U.E. | 2731 days | save | | | | |
| ?-Adrenergic Agonists Mediate Enhancement of ?1-Adrenergic eceptor N-terminal Cleavage and Stabilization in Vivo and in Vitro. | Petäjä-Repo, U.E. | 3055 days | save | | | | |
| | 
report | next » | | |
|
